American Journal of Cancer

The Extended Adjuvant Treatment Strategy in Early Breast Cancer: A New Standard of Care?
pp. 1-5(5)
Author: Smith, Ian E.

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck
pp. 7-18(12)
Authors: Saba, Nabil F.; Chen, Zhuo Georgia; Shin, Dong M.

Cost Considerations for Monoclonal Antibody-Targeted Therapy in Cancer: Focus on Trastuzumab
pp. 19-26(8)
Author: Neyt, Mattias

Preferences and Utilities of Health Outcomes and Treatments Associated with Head and Neck Cancer: A Systematic Review
pp. 27-34(8)
Authors: Komatsuzaki, Yoko; Gramegna, Paola; Stephens, Jennifer M.; Botteman, Marc F.; Pashos, Chris L.; Redaelli, Alberto

Erlotinib: In Advanced Pancreatic Cancer
pp. 35-40(6)
Authors: Simpson, Dene; Scott, Lesley J.; Noble, Stuart

Erlotinib in Advanced Pancreatic Cancer: A Viewpoint by Andrew H. Ko
pp. 41-42(2)
Author: Ko, Andrew H.

Erlotinib in Advanced Pancreatic Cancer: A Viewpoint by Henry Q. Xiong
pp. 41-42(2)
Author: Xiong, Henry Q.

Erlotinib in Advanced Pancreatic Cancer: A Viewpoint by Peter Kozuch
pp. 41-42(2)
Author: Kozuch, Peter

Bevacizumab: A Review of its Use in Advanced Colorectal Cancer, Breast Cancer, and NSCLC
pp. 43-60(18)
Authors: Lyseng-Williamson, Katherine A.; Robinson, Dean M.

The 13th European Cancer Conference (ECCO 13): 30 October - 3 November 2005, Paris, France
pp. 61-69(9)
Authors: Bothwell, Andrea; Wilde, Michelle